These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 23103902)

  • 1. Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
    O'Brien LD; Wills KL; Segsworth B; Dashney B; Rock EM; Limebeer CL; Parker LA
    Pharmacol Biochem Behav; 2013 Jan; 103(3):597-602. PubMed ID: 23103902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prior foot shock stress and Δ
    Rock EM; Limebeer CL; Petrie GN; Williams LA; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2017 Jul; 234(14):2207-2217. PubMed ID: 28424834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of delta9-tetrahydrocannabinol on quinine palatability and AM251 on sucrose and quinine palatability using the taste reactivity test.
    Jarrett MM; Scantlebury J; Parker LA
    Physiol Behav; 2007 Feb; 90(2-3):425-30. PubMed ID: 17118412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ(9) -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats.
    Rock EM; Sticht MA; Duncan M; Stott C; Parker LA
    Br J Pharmacol; 2013 Oct; 170(3):671-8. PubMed ID: 23902479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cannabinoids on lithium-induced conditioned rejection reactions in a rat model of nausea.
    Parker LA; Mechoulam R; Schlievert C; Abbott L; Fudge ML; Burton P
    Psychopharmacology (Berl); 2003 Mar; 166(2):156-62. PubMed ID: 12528012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of prevalent phytocannabinoids in the acetic acid model of visceral nociception.
    Booker L; Naidu PS; Razdan RK; Mahadevan A; Lichtman AH
    Drug Alcohol Depend; 2009 Nov; 105(1-2):42-7. PubMed ID: 19679411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews.
    Rock EM; Goodwin JM; Limebeer CL; Breuer A; Pertwee RG; Mechoulam R; Parker LA
    Psychopharmacology (Berl); 2011 Jun; 215(3):505-12. PubMed ID: 21243485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
    Taffe MA; Creehan KM; Vandewater SA
    Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel 3-substituted rimonabant analogues lack Δ(9) -tetrahydrocannabinol-like abuse-related behavioural effects in mice.
    Walentiny D; Vann R; Mahadevan A; Kottani R; Gujjar R; Wiley J
    Br J Pharmacol; 2013 May; 169(1):10-20. PubMed ID: 23297801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
    González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
    Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid agonists and antagonists modulate lithium-induced conditioned gaping in rats.
    Parker LA; Mechoulam R
    Integr Physiol Behav Sci; 2003; 38(2):133-45. PubMed ID: 14527182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced discriminative stimulus effects of Δ(9)-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys.
    McMahon LR
    Drug Alcohol Depend; 2016 Aug; 165():87-93. PubMed ID: 27289270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
    Gueye AB; Pryslawsky Y; Trigo JM; Poulia N; Delis F; Antoniou K; Loureiro M; Laviolette SR; Vemuri K; Makriyannis A; Le Foll B
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27493155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Δ-9-Tetrahydrocannabinol and Cannabidiol produce dissociable effects on prefrontal cortical executive function and regulation of affective behaviors.
    Szkudlarek HJ; Desai SJ; Renard J; Pereira B; Norris C; Jobson CEL; Rajakumar N; Allman BL; Laviolette SR
    Neuropsychopharmacology; 2019 Mar; 44(4):817-825. PubMed ID: 30538288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
    Järbe TU; Li C; Vadivel SK; Makriyannis A
    Psychopharmacology (Berl); 2008 Jul; 198(4):467-78. PubMed ID: 18264696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabinoid facilitation of behavioral and biochemical hedonic taste responses.
    De Luca MA; Solinas M; Bimpisidis Z; Goldberg SR; Di Chiara G
    Neuropharmacology; 2012 Jul; 63(1):161-8. PubMed ID: 22063718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats.
    Järbe TU; LeMay BJ; Vemuri VK; Vadivel SK; Zvonok A; Makriyannis A
    Psychopharmacology (Berl); 2011 Aug; 216(3):355-65. PubMed ID: 21369753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoid discrimination and antagonism by CB(1) neutral and inverse agonist antagonists.
    Kangas BD; Delatte MS; Vemuri VK; Thakur GA; Nikas SP; Subramanian KV; Shukla VG; Makriyannis A; Bergman J
    J Pharmacol Exp Ther; 2013 Mar; 344(3):561-7. PubMed ID: 23287700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats.
    Limebeer CL; Vemuri VK; Bedard H; Lang ST; Ossenkopp KP; Makriyannis A; Parker LA
    Br J Pharmacol; 2010 Sep; 161(2):336-49. PubMed ID: 20735419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.